Clinical Trial Update: Buspirone Treatment of Anxiety in Williams Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating buspirone for anxiety in Williams syndrome has completed, with results posted in 2024. The study was sponsored by Massachusetts General…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Williams Syndrome

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Williams Syndrome, Anxiety | Phase 4 | Status: COMPLETED | Results posted: 2024-09-19